# A rat Satb1 truncation causes neurodevelopmental abnormalities recapitulating the symptoms of patients with SATB1 mutations

## TL;DR

A rat model with a truncated Satb1 protein shows symptoms similar to human neurodevelopmental disorders, offering insights into treatment strategies.

## Contribution

A novel rat model with a Satb1 truncation was developed to study SATB1-associated neurodevelopmental disorders.

## Key findings

- Satb1 mutant rats displayed growth retardation, microcephaly, and altered vocalization.
- Clonazepam treatment alleviated social and cognitive deficits in mutant rats.
- RNA sequencing identified a cortical transcriptional network linked to neurodevelopmental disorders.

## Abstract

The special AT-rich sequence binding protein 1 (SATB1) has been linked to neurodevelopmental disorders (NDDs) including developmental delay, intellectual disabilities (ID) and autism spectrum disorder (ASD). But the underlying biological mechanisms are still not fully understood. In this study we generated a rat model with a truncated Satb1 protein. We showed that Satb1 mutant caused growth retardation, microcephaly, altered ultrasonic vocalization and delayed neurobehavioral development in mutant pups as well as social and cognitive behavior deficits in adult mutants, mimicking the typical clinical characteristics of SATB1-associated NDDs. Injection of a GABAergic enhancer clonazepam (0.04 mg/kg, i.p.) effectively alleviated the abnormal social and cognitive behaviors in Satb1 mutant rats. Finally, RNA sequencing analysis further revealed a potential role of Satb1 in a cortical transcriptional regulatory network associated with NDDs including ID and ASD. Our results confirm the crucial roles of SATB1 in the pathogenesis of NDDs and provide insights into treatment strategies for SATB1-associated NDDs.